Clinical Site 153 — St. Petersburg, Florida

Clinical Site 153 is a clinical research site located in St. Petersburg, Florida, United States 33711-1141.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Site 153 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Retinopathy.

Sponsors: OcuTerra Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St. Petersburg

Browse all research sites in Florida · View every site in St. Petersburg

• Johns Hopkins All Children's Hospital, 501 6th Avenue South (Site 840048)
• University of South Florida Allergy Immunology Clinic
• All Children's Hospital, St. Petersburg
• BayCare Medical Group Neurology at St. Anthony's Hospital
• University of South Florida at Tampa (5018)
• John's Hopkins Al Children's Hospital
• University of South Florida - Rothman Center
• Palms of Pasadina Hospital
• CFF Care Center & Pediatric Program All Children's Hospital
• University of Florida Rothman Center
• Florida All Children's Hospital
• Palms of Pasadena Hospital, Saint Petersburg, Florida

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 153?

Clinical Site 153 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 153 conducted?

Clinical Site 153 has 1 clinical trials on record. Their work covers Diabetic Retinopathy.

Is Clinical Site 153 accredited by Crixeo Clinical Trials?

Clinical Site 153 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 153?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.